IDENTIFICATION OF THE MORPHOLOGICAL PATTERN OF PROGRESSIVE PULMONARY FIBROSIS IN INTERSTITIAL LUNG DISEASES

In the current work we examined the role of lung biopsy in the diagnosis and evaluation of the progressive fibrotic phenotype in 80 patients with interstitial lung diseases. Morphological patterns with different inflammatory and fibrotic characteristics have been identified. The identified differences were correlated with the clinical data of 2 groups of patients with progressive fibrosis (n = 42) and a favorable course (n = 38). The morphological characteristics of a pattern with a probable progressive phenotype of pulmonary fibrosis in patients with interstitial lung diseases were determined. This has practical implications for patient management.

1. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias / W. D. Travis [et al.] // Am. J. Respir. Crit. Care Med. – 2013. – Vol. 188. – P. 733–748.

2. Cottin, V. Diagnostic approach of fibrosing interstitial lung diseases of unknown origin / V. Cottin, C. Valenzuela // Presse Med. – 2020. – Vol. 49. – Art. 104021.

3. Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis / M. Ghazipura [et al.] // Ann. Am. Thorac. Soc. – 2022. – Vol. 19, № 6. – P. 1040–1049.

4. Modern age pathology of pulmonary arterial hypertension / E. Stacher [et al.] // Am. J. Respir. Crit. Care Med. – 2012. – Vol. 186, № 3. – P. 261–272.

5. Predicting survival across chronic interstitial lung disease: the ILD-GAP model / C. J. Ryerson [et al.] // Chest. – 2014. – Vol. 1465145. – P. 723–728.

6. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis / G. Raghu [et al.] // N. Engl. J. Med. – 2012. – Vol. 366. – P. 1968–1977.

7. Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study) / M. Nasser [et al.] // Eur. Respir. J. – 2020. – Vol. 57, № 2002718. – P. 1–11.

8. Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease / S. L. F. Walsh [et al.] // BMC Med. – 2015. – Vol. 13, № 241. – P. 1–8.

9. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia / R. Brownell [et al.] // Thorax. – 2017. – Vol. 72. – P. 424–429.

10. What’s in a name? That which we call IPF, by any other name would act the same / A. U. Wells et al. // Eur. Respir. J. – 2018. – Vol. 51, 1800692. – P. 1–12.